Literature DB >> 11735349

Anti-inflammatory capabilities of macrolides.

J Zalewska-Kaszubska1, D Górska.   

Abstract

Macrolide antibiotics play a significant role in clinical practise due not only to their antibacterial activity, but also to their accompanying anti-inflammatory effect that is independent of their antibiotic action. Several studies reported in literature show that macrolides affect several inflammatory processes, such as migration of neutrophils, the oxidative burst in phagocytes and production of pro-inflammatory cytokines, although the precise mechanisms are not clear. They also inhibit eosinophilic inflammation and may be useful in the treatment of patients with steroid-dependent asthma. Macrolides are also effective in diffuse panbronchiolitis, chronic sinusitis and inflammatory skin diseases. Copyright 2001 Academic Press.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11735349     DOI: 10.1006/phrs.2001.0884

Source DB:  PubMed          Journal:  Pharmacol Res        ISSN: 1043-6618            Impact factor:   7.658


  10 in total

1.  Clarithromycin and pulmonary infiltration with eosinophilia.

Authors:  Claudio Terzano; Angelo Petroianni
Journal:  BMJ       Date:  2003-06-21

2.  Effect of 14-membered-ring macrolides on production of interleukin-8 mediated by protease-activated receptor 2 in human keratinocytes.

Authors:  Tatsuya Tsuda; Chika Ishikawa; Hiroe Konishi; Yoshiaki Hayashi; Noboru Nakagawa; Masato Matsuki; Hitoshi Mizutani; Kiyofumi Yamanishi
Journal:  Antimicrob Agents Chemother       Date:  2008-01-22       Impact factor: 5.191

3.  Effect of Clarithromycin on the Expression of UL16-Binding Protein 2 in Human Cells.

Authors:  Kensaku Okada; Hiroki Chikumi; Miyako Takata; Kosuke Yamaguchi; Haruhiko Makino; Tsuyoshi Kitaura; Masaki Nakamoto; Akira Yamasaki; Tadashi Igishi; Naoto Burioka; Eiji Shimizu
Journal:  Yonago Acta Med       Date:  2015-03-27       Impact factor: 1.641

4.  Induction of IL-8 by Mycoplasma pneumoniae membrane in BEAS-2B cells.

Authors:  Kathryn Chmura; Xiyuan Bai; Mari Nakamura; Pitchaimani Kandasamy; Mischa McGibney; Koji Kuronuma; Hiroki Mitsuzawa; Dennis R Voelker; Edward D Chan
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2008-05-16       Impact factor: 5.464

5.  Distribution of systemic clarithromycin to gingiva.

Authors:  Renita C Burrell; John D Walters
Journal:  J Periodontol       Date:  2008-09       Impact factor: 6.993

Review 6.  Chronic obstructive pulmonary disease: role of bacteria and guide to antibacterial selection in the older patient.

Authors:  Timothy F Murphy; Sanjay Sethi
Journal:  Drugs Aging       Date:  2002       Impact factor: 3.923

Review 7.  Macrolides: a promising pharmacologic therapy for chronic obstructive pulmonary disease.

Authors:  Shilin Qiu; Xiaoning Zhong
Journal:  Ther Adv Respir Dis       Date:  2016-12-28       Impact factor: 4.031

8.  Clarithromycin and endoscopic sinus surgery for adults with chronic rhinosinusitis with and without nasal polyps: study protocol for the MACRO randomised controlled trial.

Authors:  Carl Philpott; Steffi le Conte; David Beard; Jonathan Cook; William Sones; Steve Morris; Caroline S Clarke; Mike Thomas; Paul Little; Jane Vennik; Valerie Lund; Helen Blackshaw; Anne Schilder; Stephen Durham; Spiros Denaxas; James Carpenter; James Boardman; Claire Hopkins
Journal:  Trials       Date:  2019-04-29       Impact factor: 2.279

Review 9.  Role of macrolide therapy in chronic obstructive pulmonary disease.

Authors:  Fernando J Martinez; Jeffrey L Curtis; Richard Albert
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2008

10.  Azithromycin reduces inflammation in a rat model of acute conjunctivitis.

Authors:  Patricia Fernandez-Robredo; Sergio Recalde; Maite Moreno-Orduña; Laura García-García; Javier Zarranz-Ventura; Alfredo García-Layana
Journal:  Mol Vis       Date:  2013-01-28       Impact factor: 2.367

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.